Gainers
- Inventiva IVA stock increased by 11.2% to $4.19 during Wednesday's after-market session. The company's market cap stands at $176.1 million.
- Bluejay Diagnostics BJDX shares increased by 8.84% to $5.17. Bluejay Diagnostics's trading volume hit 5.4 million shares by close, accounting for 921.8% of its average volume over the last 100 days. The company's market cap stands at $6.4 million.
- Xilio Therapeutics XLO shares rose 8.4% to $2.45. The market value of their outstanding shares is at $67.4 million.
- Marinus Pharma MRNS shares increased by 7.71% to $7.75. The company's market cap stands at $392.2 million.
- Dare Bioscience DARE stock moved upwards by 7.49% to $0.49. The company's market cap stands at $48.0 million.
- Alzamend Neuro ALZN shares increased by 7.26% to $0.25. The market value of their outstanding shares is at $23.9 million.
Losers
- Great Elm Group GEG stock decreased by 14.7% to $1.86 during Wednesday's after-market session. The company's market cap stands at $56.9 million. The company's, Q4 earnings came out today.
- 4D Molecular Therapeutics FDMT stock fell 6.9% to $13.5. The company's market cap stands at $567.7 million.
- Perspective Therapeutics CATX stock fell 6.6% to $0.28. The company's market cap stands at $78.6 million.
- Avinger AVGR shares decreased by 6.46% to $12.9. Avinger's trading volume hit 2.3 million shares by close, accounting for 183.4% of its average volume over the last 100 days. The company's market cap stands at $8.0 million.
- Soligenix SNGX shares decreased by 6.27% to $0.48. The company's market cap stands at $4.7 million.
- Oragenics OGEN stock decreased by 6.01% to $2.82. The market value of their outstanding shares is at $7.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in